| __timestamp | HUTCHMED (China) Limited | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 580006000 |
| Thursday, January 1, 2015 | 67426000 | 676585000 |
| Friday, January 1, 2016 | 59752000 | 778966000 |
| Sunday, January 1, 2017 | 65383000 | 671251000 |
| Monday, January 1, 2018 | 70165000 | 463508000 |
| Tuesday, January 1, 2019 | 44738000 | 445724000 |
| Wednesday, January 1, 2020 | 39457000 | 399725000 |
| Friday, January 1, 2021 | 97894000 | 296656000 |
| Saturday, January 1, 2022 | 115306000 | 293122000 |
| Sunday, January 1, 2023 | 453552000 | 268323000 |
| Monday, January 1, 2024 | 304979000 |
Cracking the code
In the dynamic world of pharmaceuticals, understanding financial performance is crucial. This analysis delves into the gross profit trends of HUTCHMED (China) Limited and Taro Pharmaceutical Industries Ltd. over a decade, from 2014 to 2023.
HUTCHMED has shown a remarkable upward trend, with its gross profit surging by over 2,000% from 2014 to 2023. The most significant leap occurred in 2023, where profits skyrocketed to nearly 23 times the 2014 figures, indicating strategic growth and market expansion.
Conversely, Taro Pharmaceutical Industries Ltd. maintained a robust yet more stable performance. Despite a 54% decline from its peak in 2016, Taro's gross profit remained consistently higher than HUTCHMED's until 2023, showcasing resilience in a competitive market.
Note: Data for 2024 is incomplete, highlighting the need for ongoing analysis.
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Incyte Corporation vs HUTCHMED (China) Limited
Viatris Inc. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Comparison: Pharming Group N.V. and HUTCHMED (China) Limited Trends
Who Generates Higher Gross Profit? Grifols, S.A. or Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Analyzing Cost of Revenue: HUTCHMED (China) Limited and Taro Pharmaceutical Industries Ltd.
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis